2nd Annual Protecting & Monetising IP Assets
Time:February 04-06, 2015
Country&Region: Germany
Venue:Düsseldorf, Germany
Organizer:LSIPR、WIPR
-
Why You Should Attend
-
2nd Annual Protecting & Monetising IP Assets
With the current IP related law changes that Europe and US are undergoing, and the evolution of strategies and tools of IP management, a great deal of questions are begging answers regarding the future of IP in an intensively globalising knowledge and material world economy. Our conference intends to give answers by tackling all hot, current IP related issues.
Protecting & monetising IP assets remain a vital priority for different big innovative corporations which are in continuous quest for better IP optimization and value creation.The main concern of IP professionals and decision makers is to be able to build a strong IP strategy, to have the necessary tools, knowledge and capability to put it into execution in order to ensure value delivery to their businesses.
-
Key Topics
-
-
Increase protection for your IP assets in Europe and emerging markets
-
Improve IP portfolio valuation and mapping techniques to increase its management efficiency
-
Learn about the latest developments in the Unitary Patent and the Unified Patent Court
-
Boost your revenue flows through applying best monetisation strategies
-
Learn about Trademark, design, copyright: Best practices and law infringements
-
Previous Attendees Include
-
Agfa, Akzo Nobel, Bayer, Electrolux, Jaguar, Nokia, Shell, Sony, Vodafone ...and many more.
-
Why Choose marcus evans?
-
marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.
Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.
Pharma Sources Insight July 2025
